The Hong Kong Hospital Authority (HA) announced on Sept. 28 a study of clinical data of Chinese medicine in the treatment of recovered COVID-19 patients, indicating that Chinese medicine treatment in the recovery period can promote the resolution of residual symptoms, and improve lung functions and body constitutions.
The study was conducted between September 2020 and December 2021. The research team collected clinical data of 150 recovered COVID-19 patients, of whom more than 60 percent were women and more than 30 percent were men, ages ranging from 18 to over 80 years old, mostly middle-aged.
During the infection period, patients often experienced fever, fatigue, dry cough, muscle or joint pain, and headache….